EBITDA Margin analysis of Heron Therapeuti, FY Ratio -95.03

Loading ...

EBITDA Margin ratio Analysis of Heron Therapeuti - Deep Dive

Birds's Eye

Fundamental Analysis of Heron Therapeuti

Latest FY EBITDA Margin

Period Ending - Dec-23

-95.03

Very Poor EBITDA Margin

Period Ending - Dec-22

-164.76

Very Poor EBITDA Margin

Growth

42.32 %

Trailing Twelve Months EBITDA Margin

Period Ending - Dec-23

-60.55

Very Poor EBITDA Margin

Most recent Quarter EBITDA Margin

Period Ending - Mar-24

-11.85

Very Poor EBITDA Margin

EBITDA Margin Analysis of Heron Therapeuti

Ebitda Margin Ratio of Heron Therapeuti with value of -60.55 means that its operating expenses are Higher in relation to total revenue in trailing twelve months.
Ebitda Margin Ratio of Heron Therapeuti with value of -11.85 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Mar-24.
EBITDA Margin Ratio of HRTX rose handsomely by 42.32 % this year.
EBITDA Margin Ratio with value of -95.03 was highest in Year Dec-23 in last Five Years.
EBITDA Margin Ratio with value of -252.44 was lowest in Year Dec-21 in last Five Years.
Latest EBITDA Margin Ratio with value of -95.03 is Greater than Average EBITDA Margin of -180.23 in last five years.
Ebitda Margin of Heron Therapeuti is negative because of negative EBITDA in last Financial Year , last Quarter and also in last twelve Months

Other EBITDA Margin Related Info of HRTX that may interest you.

Heron Therapeuti Overview

Code	Price	Previous Price	Price Change	Sector
HRTX	3.2	3.22	0.621 %	Biotechnology

Fundamental Analysis Technical Analysis

Defination of EBITDA Margin

EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..

EBITDA Margin Related Ratios

NetProfitMargin

ReturnOnEquity

Tsr Profitability Index


Poor Profitability Stock

FY - Historical EBITDA Margin of Heron Therapeuti

Period	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17
EBITDA Margin	-95.03	-164.76	-252.44	-251.05	-137.86	-225.44	-624.10
Change	42.32 %	34.73 %	-0.551 %	-82.11 %	38.85 %	63.88 %	95.29 %

You are view first 7 Records. Log in to view all 37 in Premium view

FY Chart of EBITDA Margin of Heron Therapeuti

Note : All Data Generated at the End of Trading Hours (EOD Data)